Amlin PLC (LON:AML) Rating Reaffirmed
Peel Hunt now has a GBX 670.00 TP on shares of Amlin PLC (LON:AML). The TP would now indicate a potential upside of 1.48% from the current price of Amlin PLC (LON:AML). This rating was revealed to investors in an interesting research report on Monday morning.
From a total of 13 analysts covering Amlin PLC (LON:AML) stock, 2 rate it a ”Buy”, 2 a “Sell”, and 10 a ”Hold”. This means that 14% of the ratings are positive. The highest target price is GBX 675 while the lowest target price is GBX 435. The mean of all analyst targets is GBX 569.65 with a -13.97% below today’s (GBX 660.5) stock price. Amlin PLC was the topic of 17 analyst reports since August 5, 2015 according to the firm StockzIntelligence Inc. J.P. Morgan maintained shares on November 30 with “Neutral” rating. RBC Capital Markets maintained shares with “Sector Perform” rating and GBX 675 target share price in a report from a September 14. Bernstein maintained AML stock in a recent report from November 23 with “Market Perform” rating. Credit Suisse maintained the rating on September 9. Credit Suisse has a “Underperform” rating and a GBX 670 price target on shares. Finally, Barclays Capital maintained the stock with “Underweight” rating in a report issued on an October 20.
Approximately 92,647 shares of stock traded hands. Amlin plc (LON:AML) has risen 43.51% since May 8, 2015 and is uptrending. It has outperformed by 44.59% the S&P500.
Amlin plc is a United Kingdom-based independent insurer specializing in providing insurance cover to commercial enterprises and reinsurance protection to other insurance companies across the world. The company has a market cap of 3.33 billion GBP. The Company’s Amlin London segment consists of the reinsurance, property and casualty, and marine and aviation business units. It has 14.4 P/E ratio. The Company’s Amlin UK segment is engaged in underwriting commercial insurance in the United Kingdom domestic market, through Amlin Insurance Limited.